PDT Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
|
|||||
|
2025
Q1 | $586K | Buy |
|
|||||
|
2024
Q4 | $192K | Buy |
|
|||||
|
2024
Q3 | $345K | Sell |
|
|||||
|
2024
Q2 | $470K | Sell |
|
|||||
|
2024
Q1 | $694K | Sell |
|
|||||
|
2023
Q4 | $595K | Sell |
|
|||||
|
2023
Q3 | $752K | Buy |
|
|||||
|
2023
Q2 | $591K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $548K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $736K | Sell |
|
|||||
|
2021
Q2 | $1.01M | Buy |
|
|||||
|
2021
Q1 | $975K | Sell |
|
|||||
|
2020
Q4 | $1.01M | Buy |
|
|||||
|
2020
Q3 | $888K | Sell |
|
|||||
|
2020
Q2 | $1.45M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $487K | Buy |
|
|||||
|
2015
Q2 | $281K | Sell |
|
|||||
|
2015
Q1 | $431K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $1.43M | Buy |
|